Data / Federal rules / 2026-15671
Modification of Certain Terminology in Title 21; Reopening of the Comment Period
The Food and Drug Administration published this proposed rule in the Federal Register on August 3, 2026. Comments closed on October 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the proposed rule that appeared in the Federal Register of May 6, 2026, to modify certain terminology in Title 21 of the Code of Federal Regulations (CFR) to comply with Executive Order (E.O.) 14168, "Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government," issued on January 20, 2025. Specifically, this proposed rule, if finalized, will remove the term "gender" wherever it appears and either replace it with the term "sex," or delete reference to gender, as applicable, along with other editorial changes to improve readability. The Agency is taking this action to allow interested persons additional time to submit comments.
Key facts
- Document number
- 2026-15671
- Type
- Proposed rule
- Action
- Proposed rule; reopening of the comment period
- Agency
- Health and Human Services Department; Food and Drug Administration
- Published
- August 3, 2026
- Comments due
- October 2, 2026
- Dates
- FDA is reopening the comment period on the proposed rule published on May 6, 2026 (91 FR 24380). Submit either electronic or written comments on the proposed rule by October 2, 2026.
- Docket
- Docket No. FDA-2026-N-2886
- Regulation ID (RIN)
- 0910-AJ26
- Code of Federal Regulations
- 21 CFR 10; 21 CFR 56; 21 CFR 106; 21 CFR 201; 21 CFR 251; 21 CFR 310; 21 CFR 312; 21 CFR 314; 21 CFR 329; 21 CFR 600; 21 CFR 803; 21 CFR 862; 21 CFR 866; 21 CFR 870; 21 CFR 882; 21 CFR 1114
- Pages
- 2
Other documents from the Food and Drug Administration
Everything from the Food and Drug Administration · Published in August 2026
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.